Page 124 - WYSS2022 总结册-1

全国首个细胞生长因子领域的国家工程研究中心——细胞生长因子药物和蛋白制剂国
家工程研究中心在主论坛上启动，该中心于 2022 年上半年获得国家发改委建设批
复，由温州医科大学牵头建设，中国工程院院士李校堃担任主任。中心将联合地方政府、
相关高校、科研院所和产业链上下游企业，共同推动我国细胞生长因子类药物和蛋白
制剂的自主创新和快速发展。

The National Engineering Research Center for Growth Factor Drugs and Protein
Preparations, the first of its kind in the field of growth factors, was launched at the
forum. In the first half of 2022, the National Development and Reform Commission
approved the establishment of the center, the construction of which will be led by
Wenzhou Medical University. Xiaokun Li, Academician of the Chinese Academy
of Engineering will be head of the center. The center will cooperate with local
governments, relevant universities, research institutes, and upstream and downstream
enterprises of the industrial chain to jointly promote the independent innovation and
rapid development of growth factor drugs and protein preparations in China.

122